Dr Denese Marks

Adjunct Associate Professor
Medicine (Immunology &
Infectious Diseases), Central Clinical School
Australian Red Cross Blood Service

Telephone 92342369

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Johnson, L., Tan, S., Jenkins, E., Wood, B., Marks, D. (2018). Characterization of biologic response modifiers in the supernatant of conventional, refrigerated, and cryopreserved platelets. Transfusion, 58(4), 927-937. [More Information]
  • Marks, D., Loh, Y., Gstraunthaler, G., Schennach, H., Rohde, E., Laner-Plamberger, S., Oller, M., Nystedt, J., Lotf, R., et al (2018). International Forum on GMP-grade human platelet lysate for cell propagation. Vox Sanguinis, 113(1), e1-e25. [More Information]
  • Wood, B., Johnson, L., Hyland, R., Marks, D. (2018). Maximising platelet availability by delaying cold storage. Vox Sanguinis, 113(5), 403-411. [More Information]
  • Waters, L., Cameron, M., Padula, M., Marks, D., Johnson, L. (2018). Refrigeration, cryopreservation and pathogen inactivation: an updated perspective on platelet storage conditions. Vox Sanguinis, 113(4), 317-328. [More Information]
  • Korte, D., Thibault, L., Handke, W., Harm, S., Morrison, A., Fitzpatrick, A., Marks, D., Yi, Q., Acker, J. (2018). Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells. Transfusion, 58(4), 917-926. [More Information]
  • Schubert, P., Johnson, L., Marks, D., Devine, D. (2018). Ultraviolet-based pathogen inactivation systems: Untangling the molecular targets activated in platelets. Frontiers in Medicine, 5(MAY), 1-10. [More Information]
  • Waters, L., Padula, M., Marks, D., Johnson, L. (2017). Cryopreserved platelets demonstrate reduced activation responses and impaired signaling after agonist stimulation. Transfusion, 57(12), 2845-2857. [More Information]
  • Ki, K., Johnson, L., Faddy, H., Flower, R., Marks, D., Dean, M. (2017). Immunomodulatory effect of cryopreserved platelets: altered BDCA3(+) dendritic cell maturation and activation in vitro. Transfusion, 57(12), 2878-2887. [More Information]
  • Fryk, J., Marks, D., Hobson-Peters, J., Watterson, D., Hall, R., Young, P., Reichenberg, S., Tolksdorf, F., Sumian, C., Gravemann, U., et al (2017). Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light. Transfusion, 57(11), 2677-2682. [More Information]
  • Marks, D., van der Meer, P. (2017). Serum eye drops: a survey of international production methods. Vox Sanguinis, 112(4), 310-317. [More Information]
  • Acker, J., Marks, D., Sheffield, W. (2016). Quality Assessment of Established and Emerging Blood Components for Transfusion. Journal of Blood Transfusion, 2016, 1-28. [More Information]
  • Faddy, H., Fryk, J., Watterson, D., Young, P., Modhiran, N., Muller, D., Keil, S., Goodrich, R., Marks, D. (2016). Riboflavin and ultraviolet light: impact on dengue virus infectivity. Vox Sanguinis, 111(3), 235-241. [More Information]
  • Loh, Y., Johnson, L., Kwok, M., Marks, D. (2014). Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat-derived platelet concentrates. Transfusion, 54(3), 577-584. [More Information]
  • Johnson, L., Coorey, C., Marks, D. (2014). The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion, 54(8), 1917-1926. [More Information]
  • Johnson, L., Winter, K., Kwok, M., Reid, S., Marks, D. (2013). Evaluation of the quality of blood components prepared using the Reveos automated blood processing system. Vox Sanguinis, 105(3), 225-235. [More Information]
  • Johnson, L., Loh, Y., Kwok, M., Marks, D. (2013). In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system. Transfusion Medicine (Online), 23(2), 121-129. [More Information]
  • Johnson, L., Reid, S., Tan, S., Vidovic, D., Marks, D. (2013). PAS-G supports platelet reconstitution after cryopreservation in the absence of plasma. Transfusion, 53(10), 2268-2277. [More Information]
  • Tran, V., Marks, D., Duke, R., Bebawy, M., Duke, C., Roufogalis, B. (2011). Modulation of P-glycoprotein-Mediated Anticancer Drug Accumulation, Cytotoxicity, and ATPase Activity by Flavonoid Interactions. Nutrition and Cancer: an international journal, 63(3), 435-443. [More Information]

2018

  • Johnson, L., Tan, S., Jenkins, E., Wood, B., Marks, D. (2018). Characterization of biologic response modifiers in the supernatant of conventional, refrigerated, and cryopreserved platelets. Transfusion, 58(4), 927-937. [More Information]
  • Marks, D., Loh, Y., Gstraunthaler, G., Schennach, H., Rohde, E., Laner-Plamberger, S., Oller, M., Nystedt, J., Lotf, R., et al (2018). International Forum on GMP-grade human platelet lysate for cell propagation. Vox Sanguinis, 113(1), e1-e25. [More Information]
  • Wood, B., Johnson, L., Hyland, R., Marks, D. (2018). Maximising platelet availability by delaying cold storage. Vox Sanguinis, 113(5), 403-411. [More Information]
  • Waters, L., Cameron, M., Padula, M., Marks, D., Johnson, L. (2018). Refrigeration, cryopreservation and pathogen inactivation: an updated perspective on platelet storage conditions. Vox Sanguinis, 113(4), 317-328. [More Information]
  • Korte, D., Thibault, L., Handke, W., Harm, S., Morrison, A., Fitzpatrick, A., Marks, D., Yi, Q., Acker, J. (2018). Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells. Transfusion, 58(4), 917-926. [More Information]
  • Schubert, P., Johnson, L., Marks, D., Devine, D. (2018). Ultraviolet-based pathogen inactivation systems: Untangling the molecular targets activated in platelets. Frontiers in Medicine, 5(MAY), 1-10. [More Information]

2017

  • Waters, L., Padula, M., Marks, D., Johnson, L. (2017). Cryopreserved platelets demonstrate reduced activation responses and impaired signaling after agonist stimulation. Transfusion, 57(12), 2845-2857. [More Information]
  • Ki, K., Johnson, L., Faddy, H., Flower, R., Marks, D., Dean, M. (2017). Immunomodulatory effect of cryopreserved platelets: altered BDCA3(+) dendritic cell maturation and activation in vitro. Transfusion, 57(12), 2878-2887. [More Information]
  • Fryk, J., Marks, D., Hobson-Peters, J., Watterson, D., Hall, R., Young, P., Reichenberg, S., Tolksdorf, F., Sumian, C., Gravemann, U., et al (2017). Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light. Transfusion, 57(11), 2677-2682. [More Information]
  • Marks, D., van der Meer, P. (2017). Serum eye drops: a survey of international production methods. Vox Sanguinis, 112(4), 310-317. [More Information]

2016

  • Acker, J., Marks, D., Sheffield, W. (2016). Quality Assessment of Established and Emerging Blood Components for Transfusion. Journal of Blood Transfusion, 2016, 1-28. [More Information]
  • Faddy, H., Fryk, J., Watterson, D., Young, P., Modhiran, N., Muller, D., Keil, S., Goodrich, R., Marks, D. (2016). Riboflavin and ultraviolet light: impact on dengue virus infectivity. Vox Sanguinis, 111(3), 235-241. [More Information]

2014

  • Loh, Y., Johnson, L., Kwok, M., Marks, D. (2014). Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat-derived platelet concentrates. Transfusion, 54(3), 577-584. [More Information]
  • Johnson, L., Coorey, C., Marks, D. (2014). The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion, 54(8), 1917-1926. [More Information]

2013

  • Johnson, L., Winter, K., Kwok, M., Reid, S., Marks, D. (2013). Evaluation of the quality of blood components prepared using the Reveos automated blood processing system. Vox Sanguinis, 105(3), 225-235. [More Information]
  • Johnson, L., Loh, Y., Kwok, M., Marks, D. (2013). In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the INTERCEPT Blood system. Transfusion Medicine (Online), 23(2), 121-129. [More Information]
  • Johnson, L., Reid, S., Tan, S., Vidovic, D., Marks, D. (2013). PAS-G supports platelet reconstitution after cryopreservation in the absence of plasma. Transfusion, 53(10), 2268-2277. [More Information]

2011

  • Tran, V., Marks, D., Duke, R., Bebawy, M., Duke, C., Roufogalis, B. (2011). Modulation of P-glycoprotein-Mediated Anticancer Drug Accumulation, Cytotoxicity, and ATPase Activity by Flavonoid Interactions. Nutrition and Cancer: an international journal, 63(3), 435-443. [More Information]

To update your profile click here. For support on your academic profile contact .